Curriculum for Specialty Certificate Examination in Gastroenterology

Countdown to the Examination

Saturday 13 October 2012

Wilson's disease (hepatolenticular degeneration)


Dietary copper is normally absorbed from the stomach and upper small intestine. It is transported to the liver loosely bound to albumin. Here it is incorporated into apocaeruloplasmin, a glycoprotein synthesized in the liver, to produce caeruloplasmin which is secreted into the blood. Copper is normally excreted in the bile.
Wilson's disease is a very rare inborn error of copper metabolism that results in copper deposition in various organs, including the liver, the basal ganglia of the brain and the cornea.
Autosomal recessive, incidance 1in 30000.
It is potentially treatable and all young patients with liver disease must be screened for this condition.
Aetiology
Autosomal recessive disorder with a molecular defect within a copper-transporting ATPase encoded by a gene (designated ATP7B) located on chromosome 13.
It occurs world-wide, particularly in countries where consanguinity is common.

There is a failure of both incorporation and biliary excretion of copper. In the liver, copper is incorporated into caeruloplasmin and then excreted with bile.
There is a low serum caeruloplasmin in over 80% of patients owing to poor synthesis, but the precise mechanism for the failure of copper excretion is not known.

The liver histology is not diagnostic and varies from that of chronic hepatitis to macronodular cirrhosis.
Stains for copper show a periportal distribution but this can be unreliable.
The basal ganglia are damaged and show cavitation, the kidneys show tubular degeneration, and erosions are seen in bones.
Pathology
Clinical features
Children usually present with hepatic problems, whereas young adults have more neurological problems, such as tremor, dysarthria, involuntary movements and eventually dementia.
The liver disease varies from episodes of acute hepatitis, especially in children, which can go on to fulminant hepatic failure to chronic hepatitis or cirrhosis.
Typical signs are of chronic liver disease with neurological signs of basal ganglia involvement.
The presence of neurological fidings is almost synonymous with cirrhosis.

A specific sign is the Kayser-Fleischer ring, which is due to copper deposition in Descemet's membrane in the cornea. It appears as a greenish brown pigment at the corneoscleral junction just within the cornea. Identification of this ring frequently requires slit-lamp examination. It may be absent in young children.
95% of patients with neurologic or psychiatric presentation have Kayser-Fleischer ring.
Copper deposition in the lens leads to sunflower cataract, which does not interfer with vision.

Proximal renal tubular acidosis, nephrocalcinosis, aminoacidurea and hypouricaemia.
Chondrocalcinosis, OA, oesteomalcia, oesteoprosis.
Blue nails
Investigations
  1. Serum copper and caeruloplasmin
  2. Extremely low level of caeruloplasmin should be taken as strong evidance for the diagnosis of WD, but normal level does not exclude the diagnosis. Decrease total serum copper but increase in free non-caeruloplasim bound copper.
  3. Urinary copper is usually increased (100-1000 mg in 24 hours; normal levels < 40 mg in 24 hours).
  4. Liver biopsy. The diagnosis depends on measurement of the amount of copper in the liver, although high levels of copper are also found in the liver in chronic cholestasis. Measurement of 64Cu incorporation into the liver may be helpful.
  5. Haemolysis and anaemia Coomb negagtive may be present (gall stones).
  6. Genetic analysis is limited as already over 200 mutations have been identified at the ATP7B locus.
  7. low ALP/low serum uric acid may occur in asymptomatic disease or neurological disease (due to Fanconi syndrome).
Treatment
Lifetime treatment with penicillamine, 1-1.5 g daily, is effective in chelating copper.
If treatment is started early, clinical and biochemical improvement can occur.
Urine copper levels should be monitored and the drug dose adjusted downwards after 2-3 years.
Serious side-effects of the drug occur in 10% and include skin rashes, leucopenia and renal damage.
Need to supplement pyridoxine
Trientine is the second line treatment for patients intolerant to penicillamine.
Oral Zinc is the third line. It compete eith copper for intestinal absorption.
Tetrathiomolybdate suitable for severe neurologic WD
Avoid chocolate, shellfish, liver, nuts, mushrooms.

All siblings and children of patients should be screened and treatment given even in the asymptomatic if there is evidence of copper accumulation.

Prognosis
Early diagnosis and effective treatment have improved the outlook. Neurological damage is, however, permanent. Fulminant hepatic failure or decompensated cirrhosis should be treated by liver transplantation.

Copper metabolism, my gastro room blog

4 comments:

  1. A 50-year-old man is diagnosed with Wilson's disease. You are trying to make sense of his blood test results.
    Which one of the following would you expect to find in a patient with Wilson's disease?
    (Please select 1 option)
    1- Hypercalcaemia
    2- Positive anti-mitochondrial antibody
    3-Raised caeruloplasmin
    4-Raised free serum copper Correct
    5-Reduced urinary copper


    Wilson's disease typically causes

    reduced caeruloplasmin
    raised urinary copper
    raised free serum copper
    Primary biliary cirrhosis typically causes a positive anti-mitochondrial antibody.

    ReplyDelete
  2. Anemia in patients with acute Wilson’s crisis is due to significant hemolysis. One other feature that is very suggestive of acute Wilson’s liver failure is alkaline phosphatase to bilirubin ratio < 2.0. It is not clear why the serum levels of alkaline phosphatase are drastically decreased in patients with acute liver failure due to Wilson’s disease. But alkaline phosphatase to bilirubin ratio < 2.0 in a patient with acute liver failure should always the raise of suspicion for Wilson’s disease.
    Slit lamp examination oftentimes provides immediate diagnostic clues (by exhibiting KF rings) and should be obtained in every patient with acute liver failure with any suspicion of Wilson’s disease.

    ReplyDelete
  3. A 17-year-old otherwise healthy girl notes that her urine has become darker than usual and she is having a difficult time concentrating in school. Routine blood work is found to be significant for a hemoglobin level of 8 g/dL. Liver test results are significant for a total bilirubin of 9 mg/dL, alkaline phosphatase of 90 U/L, AST of 700 U/L, and ALT of 890 U/L. Hepatitis A/B/C serology results are negative. Which is the most likely diagnosis?

    1-Alcoholic hepatitis
    2-Ischemic hepatitis
    3-Wilson disease
    4-Amanita phalloides poisoning
    5-Autoimmune hepatitis (AIH)

    This patient has Wilson’s disease. Wilson’s disease is most commonly diagnosed in children and young adults and should be suspected in this age group. This disorder results from a defect in the ATP7A gene and results in copper retention in the liver resulting in hepatocyte injury. Patients can present in various ways, from asymptomatic abnormalities in blood work to fulminant hepatic failure. Patients presenting with severe acute Wilson’s disease are often noted to have hemolysis with an elevated hyperbilirubinemia and anemia resulting in jaundice. AST and ALT levels are often quite elevated compared with the alkaline phosphatase, which is either normal or below normal in acute settings. Patients presenting in this manner need to be diagnosed expeditiously and transferred to a liver transplantation facility as copper chelators are not beneficial in this setting.

    ReplyDelete
  4. A 16-year-old high school student is brought to the emergency department by his mother because over the past two or three days he has become lethargic and confused. His family has noticed that over the past few months, he has become withdrawn and irritable and started to have problems with homework. Laboratory test results show that his hemoglobin level is 10.6 g/dL, total bilirubin is 26.4 mg/dL, direct bilirubin is 7.9 mg/dL, AST is 934 U/L, ALT is 788 U/L, alkaline phosphatase is 104 U/L, and INR is 1.7. Which of the following is the most appropriate course of treatment for this patient?

    1-Administer intravenous N-acetylcysteine.
    2-Initiate a transplantation evaluation.
    3-Initiate penicillamine therapy.
    4-Infuse α1-antitrypsin.
    5-Begin therapeutic phlebotomy.

    This patient has Wilson’s disease and is presenting with fulminant hepatic failure with severe coagulopathy and encephalopathy. Acute intravascular hemolysis is usually present in this situation. Unlike fulminant viral hepatitis, Wilson’s disease is usually characterized by disproportionately low serum aminotransaminase levels, and the serum alkaline phosphatase level is in the normal or even low range. The serum bilirubin level is disproportionately elevated secondary to hemolysis. These patients do not respond well to chelation therapy and require urgent transplantation evaluation.

    ReplyDelete